课题基金 / 基金详情

PROHIBITIN GENE IN GROWTH CONTROL AND TUMOR SUPPRESSION

PROHIBITIN GENE IN GROWTH CONTROL AND TUMOR SUPPRESSION
抑制素基因在生长控制和肿瘤抑制中的作用
批准号:
7413414
负责人:
SRIKUMAR P. CHELLAPPAN
金额:
$27.23万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2010-03-31

项目摘要

项目成果

SRIKUMAR P. CHELLAPPAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):哺乳动物细胞通过增殖、分化或凋亡对多种细胞外信号作出反应。这些事件受到包括信号分子、肿瘤抑制蛋白、转录因子及其下游靶标的复杂机制的严格调控。本研究将重点探讨Prohibitin在上述过程中的作用。Prohibitin基因定位于染色体17q21,在散发性乳腺癌中发现其突变。我们前期的研究表明,prohibitin可以与视网膜母细胞瘤肿瘤抑制蛋白结合,抑制E2F家族成员的转录活性。这是prohibitin抑制细胞增殖所必需的。我们最近的研究表明prohibitin可以增强p53的转录活性。基于这些发现,我们将研究是否转录辅助抑制因子HP1和SUV 39 H有助于E2F1活性的抑制,以及是否抑制蛋白有助于异染色质的形成在细胞衰老过程中。将尝试了解如何抑制调节YY1启动子,这如何有助于调节细胞增殖。接下来我们将研究prohibitin促进p53募集到启动子,导致其激活的机制。我们将集中在是否prohibitin影响p53的四聚体以及其翻译后修饰。最后一个具体的目标将集中在体内模型,研究抑制素的功能。我们已经产生了转基因小鼠乳腺上皮细胞过度表达prohibitin。我们将研究抑制素对乳腺发育的影响以及致癌物和Ras诱导的乳腺癌。实验正在进行中,以产生条件性抑制素敲除小鼠。我们希望这些实验将有助于阐明参与阿比丁介导的生长控制和肿瘤抑制的分子机制。
英文摘要
DESCRIPTION (provided by applicant): Mammalian cells respond to a variety of extracellular signals by undergoing proliferation, differentiation or apoptosis. These events are stringently regulated by a complex machinery comprising of signaling molecules, tumor suppressor proteins, transcription factors and their downstream targets. This proposal will focus on the role of Prohibitin, a potential tumor suppressor protein, in the above processes. Prohibitin gene is located on chromosome 17q21 and its mutations have been found in sporadic breast cancers. Our earlier studies had shown that prohibitin could bind to the retinoblastoma tumor suppressor protein and repress the transcriptional activity of E2F family members. This was necessary for prohibitin to inhibit cell proliferation. Our recent studies show that prohibitin could enhance the transcriptional activity of p53. Based on these findings, we will examine whether the transcriptional co-repressors HP1 and SUV39H contribute to prohibitin-mediated repression of E2F1 activity and whether prohibitin contributes to heterochromatin formation during cellular senescence. Attempts will be made to understand how prohibitin regulates the YY1 promoter and how this contributes to regulation of cell proliferation. We will next examine the mechanisms by which prohibitin facilitates the recruitment of p53 to promoters, leading to its activation. We will focus on whether prohibitin influences the tetramerization of p53 as well as its post-translational modifications. The last specific aim will focus on in vivo models to study prohibitin function. We have generated transgenic mice over-expressing prohibitin in mammary epithelial cells. We will examine the effects of prohibitin on mammary gland development as well as carcinogen and Ras induced breast carcinoma. Experiments are in progress to generate a conditional prohibitin knock-out mice. We expect that these experiments will help elucidate the molecular mechanisms involved in prohibitin-mediated growth control and tumor suppression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
TBK1 mediated regulation of E2F1 as a therapeutic target in non-small cell lung cancer
TBK1 mediated regulation of E2F1 as a therapeutic target in non-small cell lung cancer
Role of Id1 in NSCLC Progression and Metastasis
海外基金